Dialysis biofeedback in hemodiafiltration with online regeneration of ultrafiltrate (HFR) could help to improve arterial hypertension. We evaluated the impact of isonatric HFR (HFR-iso) on hypertension control compared to conventional HFR. Forty-seven hemodialysis patients were included and randomized (ratio 2/1) HFR-iso versus HFR during 24 dialysis sessions. In the HFR-iso group (32 patients, 768 dialysis sessions), the predialytic systolic blood pressure (BP) decreased from S1 to S24 of 9 ± 20 mm Hg and increased of 5 ± 24 mm Hg in the HFR group (15 patients, 360 dialysis sessions), variation that differed between the 2 groups (ΔS1-S24, p = 0.035; interaction group*time, p = 0.012). The diastolic BP (HFR-iso -3 ± 14 mm Hg vs. HFR 5 ± 13 mm Hg; p = 0.088), the DDD of antihypertensive treatment and the dry weight did not vary significantly during the study. Number of sessions complicated by symptomatic hypotension was similar in the 2 groups. HFR-iso improved BP control without increasing dialysis hypotension episodes. Short Summary: In this multicenter, open-label, controlled, randomized study, we evaluated the impact of dialysis biofeedback in HFR on arterial hypertension compared to conventional HFR. We observed that HFR-iso improved arterial BP control without increasing dialysis hypotension episodes.

Keywords:
Hypertension, Hemodialysis, Sodium, Biofeedback, Dialysis
1.
Heerspink HJ, Ninomiya T, Zoungas S, de Zeeuw D, Grobbee DE, Jardine MJ, et al: Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials. Lancet 2009;373:1009-1015.
2.
Agarwal R, Alborzi P, Satyan S, Light RP: Dry-weight reduction in hypertensive hemodialysis patients (DRIP): a randomized, controlled trial. Hypertension 2009;53:500-507.
3.
David S, Kümpers P, Eisenbach GM, Haller H, Kielstein JT: Prospective evaluation of an in-centre conversion from conventional haemodialysis to an intensified nocturnal strategy. Nephrol Dial Transplant 2009;24:2232-2240.
4.
Nesrallah GE, Suri RS, Guyatt G, Mustafa RA, Walter SD, Lindsay RM, et al: Biofeedback dialysis for hypotension and hypervolemia: a systematic review and meta-analysis. Nephrol Dial Transplant 2013;28:182-191.
5.
Locatelli F, Andrulli S, Di Filippo S, Redaelli B, Mangano S, Navino C, et al: Effect of on-line conductivity plasma ultrafiltrate kinetic modeling on cardiovascular stability of hemodialysis patients. Kidney Int 1998;53:1052-1060.
6.
Moret K, Aalten J, van den Wall Bake W, Gerlag P, Beerenhout C, van der Sande F, et al: The effect of sodium profiling and feedback technologies on plasma conductivity and ionic mass balance: a study in hypotension-prone dialysis patients. Nephrol Dial Transplant 2006;21:138-144.
7.
Locatelli F, Stefoni S, Petitclerc T, Colì L, Di Filippo S, Andrulli S, et al: Effect of a plasma sodium biofeedback system applied to HFR on the intradialytic cardiovascular stability. Results from a randomized controlled study. Nephrol Dial Transplant 2012;27:3935-3942.
8.
Movilli E, Camerini C, Gaggia P, Zubani R, Feller P, Poiatti P, et al: Role of dialysis sodium gradient on intradialytic hypertension: an observational study. Am J Nephrol 2013;38:413-419.
9.
Thomson BK, Dixon SN, Huang SH, Leitch RE, Suri RS, Chan CT, et al: Modifiable variables affecting interdialytic weight gain include dialysis time, frequency, and dialysate sodium. Hemodial Int 2013;17:576-585.
10.
Nigwekar SU, Wenger J, Thadhani R, Bhan I: Hyponatremia, mineral metabolism, and mortality in incident maintenance hemodialysis patients: a cohort study. Am J Kidney Dis 2013;62:755-762.
11.
Sarkar SR, Wystrychowski G, Zhu F, Usvyat LA, Kotanko P, Levin NW: Fluid dynamics during hemodialysis in relationship to sodium gradient between dialysate and plasma. ASAIO J 2007;53:339-342.
12.
de Paula FM, Peixoto AJ, Pinto LV, Dorigo D, Patricio PJ, Santos SF: Clinical consequences of an individualized dialysate sodium prescription in hemodialysis patients. Kidney Int 2004;66:1232-1238.
13.
Manlucu J, Gallo K, Heidenheim PA, Lindsay RM: Lowering postdialysis plasma sodium (conductivity) to increase sodium removal in volume-expanded hemodialysis patients: a pilot study using a biofeedback software system. Am J Kidney Dis 2010;56:69-76.
14.
Selby NM, Taal MW, McIntyre CW: Comparison of progressive conductivity reduction with diacontrol and standard dialysis. ASAIO J 2007;53:194-200.
15.
Mercadal L, Piékarski C, Renaux JL, Petitclerc T, Deray G: Isonatric dialysis biofeedback in hemodiafiltration with online regeneration of ultrafiltrate (HFR): rationale and study protocol for a randomized controlled study. J Nephrol 2012;25:1126-1130.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.